Towards Healthcare
Microcarriers Market 2025 Sees Valuation of USD 1.96 Billion

Microcarriers Market Size Soars in 2025 as Asia Pacific Emerges Fastest-Growing Region with Biotech Expansion

Based on market forecasts, the microcarriers sector will expand from USD 1.76 billion in 2024 to USD 5.21 billion by 2034, experiencing a CAGR of 11.48%.The microcarriers market is growing due to they are broadly applied in medical regeneration, including use in cell expansion/bioreactors, scaffold combinations, micro-tissue and disease models, cargo delivery, and bioprinting. North America is dominated in the market by a strong presence of the biopharmaceutical industry and significant government funding.

  • Insight Code: 5841
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The microcarriers market is projected to reach USD 5.21 billion by 2034, growing at a CAGR of 11.48% from 2024 to 2034.

North America is currently leading the microcarriers market due to the growing number of biopharmaceutical companies and a high level of R&D activity.

The Microcarriers Market includes six segments such as by product type, by material type, by type of microcarrier, by application, by end user, and by region.

Some key players include Thermo Fisher Scientific Inc., Merck KGaA (MilliporeSigma), Cytiva (Danaher Corporation), Corning Incorporated, and Lonza Group AG.

Key trends include the integration of microcarriers with perfusion systems and the development of biodegradable microcarriers.

Microcarriers can be divided into three main categories: nonporous and microporous microcarriers, whose matrix can be made of materials like polystyrene or dextran, respectively, and macroporous microcarriers, which can be made of cellulose or gelatin.

Microcarriers are supportive structures for cell growth and expansion they are made of synthetic (i.e., dextran, plastic, glass) or natural (cellulose, gelatin, and collagen) materials with specific engineered porosities.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.